We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Expert Opinion / Commentary · December 05, 2013

Pregnancy Prevention on Isotretinoin: Practical Recommendations

Written by
Hilary E. Baldwin MD


Additional Info

  1. Espey E, Ogburn T. Long active reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol 2011 Mar;117(3):705-19

  2. Tyler C, Whiteman M, Zapata L, et al. Health care practitioner attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol 2012;Apr, 119(4):762-71

  3. American College of Obstetrics and Gynecology Practice Bulletin 121: Long acting reversible contraceptive implants and intrauterine devices. Obstet Gynecol 2011;118:184-96

  4. Rosenbaum J. Patient teenagers? A comparison of the sexual behavior of virginity pledgers and matched nonpledgers. Pediatrics 2009 123(1):e110-120

  5. Collins M, Moreau J, Opel D, et al. Compliance with pregnancy prevention measures during isotretinoin therapy. J Am Acad Dermatol. 2013 Oct 21 Epub

Disclosure statements are available on the authors' profiles:

Further Reading